Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine: Mechanisms and Relevance to Treatment of Depression
Ji‐Woon Kim, Kanzo Suzuki, Ege T. Kavalali, et al.
Annual Review of Medicine (2023) Vol. 75, Iss. 1, pp. 129-143
Closed Access | Times Cited: 51

Showing 26-50 of 51 citing articles:

Dedication
Barry S. Fogel, Xiaoling Jiang
Oxford University Press eBooks (2025), pp. v-vi
Closed Access
The Dark Side of Creative Talent
Barry S. Fogel, Xiaoling Jiang
Oxford University Press eBooks (2025), pp. 521-570
Closed Access
Physicians in Pain: Depression in the Medical Profession
Barry S. Fogel, Xiaoling Jiang
Oxford University Press eBooks (2025), pp. 571-626
Closed Access
Application of Optogenetic Neuromodulation in Regulating Depression
Jin Zhang, Xiang Peng, Man Li, et al.
Current Medical Science (2025)
Closed Access
Hypericum perforatum L. attenuates depression by regulating Akkermansia muciniphila, tryptophan metabolism and NFκB-NLRP2-Caspase1-IL1β pathway
Zheng‐Meng Jiang, Fangfang Wang, Yuanyuan Zhao, et al.
Phytomedicine (2024) Vol. 132, pp. 155847-155847
Closed Access | Times Cited: 4
Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches
Aline Silva de Miranda, Eliana Cristina de Brito Toscano, Venugopal Reddy Venna, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-15
Closed Access
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
Effect of esketamine on postoperative depression in women with breast cancer and preoperative depressive symptoms: The EASE randomized trial
Qingfeng Wei, Mengmeng Li, Qiuling Du, et al.
Journal of Clinical Anesthesia (2025) Vol. 103, pp. 111821-111821
Closed Access
The N -methyl- d -aspartate receptor hypothesis of ketamine’s antidepressant action: evidence and controversies
Yihao Jiang, Yiyan Dong, Hailan Hu
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1906
Open Access | Times Cited: 3
Selective disruption of mTORC1 and mTORC2 in VTA astrocytes induces depression and anxiety-like behaviors in mice
Ziteng Zheng, Han Zhou, Lu Yang, et al.
Behavioural Brain Research (2024) Vol. 463, pp. 114888-114888
Open Access | Times Cited: 2
Common changes in rat cortical gene expression after antidepressant drug treatment: Impacts on metabolism of polyamines, mRNA splicing, regulation of RAS by GAPs, neddylation and GPCR ligand binding
Brian Dean, Elizabeth Scarr
The World Journal of Biological Psychiatry (2024) Vol. 25, Iss. 3, pp. 200-213
Closed Access | Times Cited: 2
Distinct synaptic mechanisms drive the behavioral response to acute stress and rapid correction by ketamine
Ji‐Woon Kim, Benjamin Kleinfelter, Ege T. Kavalali, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 12, pp. 1916-1924
Open Access | Times Cited: 2
Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD)
Berend Olivier, Berend Olivier
Advances in experimental medicine and biology (2024), pp. 49-66
Closed Access | Times Cited: 2
Ketamine, an Old–New Drug: Uses and Abuses
Katarina Savić Vujović, Ana Jotić, Branislava Medić, et al.
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 16-16
Open Access | Times Cited: 6
Ketamine-Induced Sclerosing Cholangitis Associated With Early Inflammatory Bowel Disease During Chronic Topical Ketamine Use
Gerond Lake‐Bakaar, Benjamin Milgrom, Clark C. Kulig, et al.
Gastro Hep Advances (2024) Vol. 3, Iss. 4, pp. 471-473
Open Access | Times Cited: 1
Research Progress on NMDA Receptor Enhancement Drugs for the Treatment of Depressive Disorder
Ruyun Liu, Ning Liu, Lin Ma, et al.
CNS Drugs (2024) Vol. 38, Iss. 12, pp. 985-1002
Closed Access | Times Cited: 1
New pharmacotherapies to tackle the unmet needs in bipolar disorder: a focus on acute suicidality
Georgios D. Kotzalidis, Federica Fiaschè, Alessandro Alcibiade, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 435-446
Closed Access
Innovative Ketamine Formulations: Enhancing Therapeutic Efficacy and Safety
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1188-1190
Closed Access
Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol
Josh Martin, Fatemeh Gholamali Nezhad, Alice Rueda, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0308413-e0308413
Open Access
Late-onset major depressive disorder: exploring the therapeutic potential of enhancing cerebral brain-derived neurotrophic factor expression through targeted microRNA delivery
Giovanni Lai, Marco Malavolta, Serena Marcozzi, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access
KETAMINE: Neural- and network-level changes
Vishal Bharmauria, Hamidreza Ramezanpour, Afef Ouelhazi, et al.
Neuroscience (2024) Vol. 559, pp. 188-198
Closed Access
An historical overview of artificial intelligence for diagnosis of major depressive disorder
Hao Liu, Hairong Wu, Zhongli Yang, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
5-HT1B receptor activation produces rapid antidepressant-like effects in rodents
Erin A. S. Clark, Lien Wang, Taleen Hanania, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 247, pp. 173917-173917
Closed Access
Advancements in NMDA Receptor-Targeted Antidepressants: From d-Cycloserine Discovery to Preclinical Efficacy of Lu AF90103
Erhad Ascic, Mauro Marigo, Laurent David, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Ketamin in Anästhesie und Intensivmedizin
Sabine Himmelseher, Christine H. Meyer‐Frießem
Springer Reference Medizin (2024), pp. 1-13
Closed Access

Scroll to top